“…This differential activity is likely dependent on specific FOXL2 binding partners that constitute the transcriptional complex leading to gene regulation (Fleming et al, 2010; Pisarska et al, 2010, 2011; Georges et al, 2013) as well as post-translational modifications (PTMs) and variant alternative FOXL2 binding sites (see below). A variety of protein binding partners of FOXL2 have been reported, including DEAD box-containing protein (DP103; Lee et al, 2005), SMAD3 (Blount et al, 2009), ER alpha, (Kim et al, 2009), Steroidogenic factor-1 (SF-1; Park et al, 2010), UBC9, PIAS1 (Marongiu et al, 2010), LATS1 (Pisarska et al, 2010), FOXL2 itself (Kuo et al, 2011), CXXC4, CXXC5, CREM, GMEB1, NR2C1, SP100, RPLP1, BANF1, XRCC6, SIRT1 LâHĂ´te et al, 2012), GSK3β, MDM2 (Kim et al, 2014) and NOBOX (Bouilly et al, 2014). …”